Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,307 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Active, Not Recruiting

VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

NCT06249165

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations
  • Univ. of Alabama - Birmingham Birmingham, Alabama, United States
  • Univ. of California - Irvine Orange, California, United States
  • San Francisco General Hospital San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)

NCT06545136

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Lysosomal Rare Disorders Research and Treatment Center Fairfax, Virginia, United States
  • Hospital de Clinicas de Porto Alegre (HCPA) Porto Alegre, Brazil
  • Hospital Quironsalud Zaragoza Zaragoza, Spain
  • Salford Royal Hospital Salford, United Kingdom
View Trial Details
Active, Not Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

NCT06347016

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Research Site 1 Birmingham, Alabama, United States
  • Research Site 2 Mobile, Alabama, United States
  • Research Site 3 Beverly Hills, California, United States
  • Research Site 4 Canoga Park, California, United States
View all 149 locations
View Trial Details
Active, Not Recruiting

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

NCT06492291

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0027) Daphne, Alabama, United States
  • G&L Research ( Site 0035) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0029) Beverly Hills, California, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

Anti-obesity Pharmacotherapy and Inflammation

NCT05756764

Conditions
Body Weight, Dyslipidemias, Glucose Metabolism Disorders, +14 more
Locations
  • LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO New Orleans, Louisiana, United States
  • Ochsner Health System - Biospecimen New Orleans, Louisiana, United States
View Trial Details

Related conditions